Chlorambucil-induced cytomegalovirus infection: a case report

María Thiscal López-Lluva1, María Dolores Sanchez de la Nieta-García, Jesús Piqueras-Flores

  • 1Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Calle del Obispo Rafael Torija s/n, 13005 Ciudad Real, España. mtl.lluva@gmail.com.

Abstract

Insights

Cytomegalovirus infection can manifest with respiratory symptoms in patients treated with chlorambucil for idiopathic membranous nephropathy. Prompt antiviral treatment with ganciclovir led to full remission in a reported case.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Oncology

Background:

  • Idiopathic membranous nephropathy is often treated with chlorambucil and corticosteroids.
  • Chlorambucil, an alkylating agent, is generally well-tolerated but can cause myelosuppression and infections.

Observation:

  • An 81-year-old male with idiopathic membranous nephropathy developed fever, cough, dyspnea, pulmonary infiltrates, and abdominal pain after starting chlorambucil and corticosteroids.
  • Virology tests confirmed a recent cytomegalovirus (CMV) infection.

Findings:

  • The patient's symptoms, including respiratory distress and pulmonary infiltrates, were attributed to cytomegalovirus infection.
  • Antiviral therapy with ganciclovir resulted in complete resolution of symptoms and remission.

Implications:

  • Cytomegalovirus infection should be considered in the differential diagnosis of patients on chlorambucil therapy presenting with respiratory symptoms and pulmonary infiltrates.
  • Early recognition and treatment of CMV infection are crucial for managing complications in patients undergoing immunosuppressive therapy for nephrotic syndrome.